Mutations of KRAS oncogene and tumor suppressor genes such as p16, p53, DPC4, BRCA2, LKB1, and MKK4 were detected in pancreatic cancers at varied frequencies (reviewed in [2]). This evidence concerns the gene CDKN2A and pancreatic neoplasm.